Investigating the Impact of IL-6 and CXCL8 on Neurodegeneration and Cognitive Decline in Alzheimer Disease
International Journal of Neuropsychopharmacology · 2024
DOI: 10.1093/ijnp/pyae038 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neuropsychopharmacology, 2024. Verfasst von Dongdong Jin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Interleukin-8, Interleukin-6, Cognitive Dysfunction. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer disease (AD) is a progressive neurodegenerative disorder primarily affecting the elderly, characterized by severe cognitive impairment and memory loss. Emerging evidence suggests that neuroinflammation plays a significant role in AD pathogenesis, with cytokines like interleukin-6 (IL-6) and C-X-C motif chemokine ligand 8 (CXCL8) contributing to the disease progression.
Methods
We utilized Gene Expression Omnibus datasets to identify IL-6 and CXCL8 as pivotal inflammatory markers in AD. In vitro experiments were conducted using SK-N-BE(2)-M17 and THP-1 cell lines treated with IL-6 and CXCL8 to model AD. Additionally, in vivo tests on Amyloid Precursor Protein/Presenilin 1 (APP/PS1) AD mouse models were performed to assess the impact of these cytokines on cognitive functions and brain pathology.
Results
The results indicated a significant decrease in cell viability, increased apoptosis, and elevated inflammatory factor secretion following IL-6 and CXCL8 treatment in vitro. In vivo, AD mouse models treated with these cytokines exhibited exacerbated emotional distress, decreased social interaction, impaired cognitive functions, and increased amyloid protein deposition in neural tissues.
Conclusions
The study highlights the detrimental effects of IL-6 and CXCL8 on neuronal health and cognitive functions in AD. These findings suggest that targeting these cytokines could offer potential therapeutic interventions for improving patient outcomes in Alzheimer disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Min Zhang
Zitieren
APA
Jin, D., Zhang, M., Shi, L., & Liu, H. (2024). Investigating the Impact of IL-6 and CXCL8 on Neurodegeneration and Cognitive Decline in Alzheimer Disease. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae038
Vancouver
Jin D, Zhang M, Shi L, Liu H. Investigating the Impact of IL-6 and CXCL8 on Neurodegeneration and Cognitive Decline in Alzheimer Disease. International Journal of Neuropsychopharmacology. 2024. doi:10.1093/ijnp/pyae038
BibTeX
@article{Jin2024,
author = {Jin, Dongdong and Zhang, Min and Shi, Lei and Liu, Hengfang},
title = {Investigating the Impact of IL-6 and CXCL8 on Neurodegeneration and Cognitive Decline in Alzheimer Disease},
journal = {International Journal of Neuropsychopharmacology},
year = {2024},
doi = {10.1093/ijnp/pyae038}
}
EUVIMED